Anonymous ID: 8a650a Aug. 7, 2026, 3:50 a.m. No.24910471   🗄️.is 🔗kun   >>0478 >>0558 >>0596 >>0623

>>24910421

Moderna’s New mRNA Flu ‘Vaccine’ Wins FDA Approval

 

https://www.zerohedge.com/news/2026-08-06/modernas-new-mrna-flu-vaccine-wins-fda-approval

 

In what is difficult to frame, try as apologists might, as anything other than a fresh betrayal of the MAHA coalition for the benefit of the pharmaceutical industry at the expense of (actual) public health, the FDA has just approved a Moderna mRNA influenza “vaccine” (mRNA shots being more accurately described as gene therapy than conventional vaccines).

 

Via Reuters:

 

“The U.S. Food and Drug Administration has approved Moderna’s (MRNA.O) flu vaccine for people aged 50 and older, the company said on Wednesday, marking the first approval of a messenger RNA-based vaccine ​for seasonal flu.

 

The shot, mFlusiva, was given a traditional approval for adults aged ‌50 to 64, and an accelerated approval for those 65 years and older…

 

Moderna has agreed to run an additional study and submit more data in adults 65 and older to confirm the vaccine’s benefit in that age group…

 

The approval was based on data from a ⁠late-stage trial involving more than 40,000 adults aged 50 and older, which showed the shot was ​26.6% more effective than a licensed standard-dose flu vaccine.

 

The company also submitted separate late-stage data showing the ​vaccine generated stronger antibody responses than Sanofi’s high-dose flu vaccine in adults 65 and older.

 

MFlusiva would compete with flu vaccines from Sanofi (SASY.PA),, GSK (GSK.L), CSL Seqirus (CSL.AX),, and AstraZeneca (AZN.L)…

 

Jefferies analysts had forecast $750 million in U.S. sales of Moderna’s flu shot and combination COVID-flu vaccine by 2030.”